Fritextsökning
Innehållstyper
-
Specific proposals and targets top the universities’ desired priorities
What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...
-
Quiet, fast, inexpensive: mass flow controller for life sciences
Whether in portable oxygen system devices or in bioreactors, the new proportional flow control valve VEMD from Festo provides extremely high control dynamics an...
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
AI-Driven Microscopy Image Analysis in Pharma and Biotech
Extract breakthrough discoveries from large, complex data sets.
-
Första läkemedlet mot förlossningsdepression får grönt ljus i EU
EU-kommissionen har för första gången godkänt ett läkemedel mot förlossningsdepression, närmare bestämt amerikanska Biogens Zurzuvae.
-
Unexpected study results on testosterone – no reduction in fracture risk
Testosterone treatment is known to increase bone density and bone quality. However, a study now suggests that supplementation with the male sex hormone does not...
-
Suing the company – for NOT developing a new HIV drug
Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...
-
Don't miss ZEISS Quality Innovation Days
Digital event April 15-19, 2024.
-
Conference recordings now available
Don't miss out on insights from leading experts.
-
Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience
Case study by ZEISS Microscopy.
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
”Information security must become part of the Swedish life science strategy”
Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.
-
Halsfluss i fokus när Magnus Gisslén ryter vidare
Magnus Gissléns sågning av Folkhälsomyndigheten (FHM) fortsätter och nu riktar han ljuset mot användning av antibiotika vid halsfluss. Han kritiserar också nätv...
-
Improved processes and more
Discover the full potential and benefits.
-
Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas
Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
Anna Törner: The clinical trial – Periscope to reality
What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
Ancient DNA provides new insights – “The immune system lost its job”
Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
-
New large lab building in Lund inaugurated – here are the companies moving in
Medicon Village has received a new laboratory building. On Friday last week the building was inaugurated with a ribbon-cutting ceremony by Minister for Employme...
-
Norwegian cancer research companies merge
The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.
-
Study: Popular diabetes drug may be effective against liver disease
After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...
-
Settlement of cancer allegations against blockbuster drug
French pharmaceutical company Sanofi has reached a principal agreement in the US on around 4,000 of the cases in which its now withdrawn blockbuster heartburn d...
BREAKING